|1.||Westphal, Martin: 16 articles (06/2011 - 02/2003)|
|2.||Morelli, Andrea: 15 articles (12/2013 - 04/2004)|
|3.||Ertmer, Christian: 13 articles (06/2011 - 08/2006)|
|4.||Ginès, Pere: 9 articles (02/2015 - 10/2002)|
|5.||Krag, Aleksander: 9 articles (09/2013 - 12/2007)|
|6.||Bendtsen, Flemming: 9 articles (05/2013 - 05/2005)|
|7.||Tsianos, Epameinondas V: 9 articles (08/2012 - 07/2005)|
|8.||López-Herce, Jesús: 8 articles (01/2015 - 01/2006)|
|9.||Møller, Søren: 8 articles (05/2013 - 05/2005)|
|10.||Lange, Matthias: 8 articles (05/2011 - 09/2007)|
04/01/2012 - "In patients with esophageal variceal bleeding, a 24-h course of terlipressin is as effective as a 72-h course when used as an adjunctive therapy to successful EVBL."
04/01/2010 - "In patients with variceal bleeding, the bleeding control is significantly improved by early administration of terlipressin. "
09/01/1991 - "High-dose terlipressin (84%) seemed to be more effective in the initial control of bleeding than low-dose terlipressin (67%); however this difference was not significant. "
05/01/2005 - "Portal hypotensive effect of terlipressin is less effective when given during hemorrhage than in stable state. "
01/01/2003 - "On the basis of a 34% relative risk reduction in mortality, terlipressin should be considered to be effective in the treatment of acute variceal hemorrhage. "
05/01/2011 - "Finally, we understand its use associated to terlipressin seems to be the best treatment strategy for type I hepatorenal syndrome. "
10/01/2008 - "Studies suggest that terlipressin is effective in the treatment of hepatorenal syndrome (HRS). "
03/01/2012 - "Treatment with terlipressin and albumin has been reported recently to be effective in improving renal function in the treatment of cirrhotic patients with hepatorenal syndrome (HRS). "
01/01/2010 - "Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. "
11/01/2009 - "Terlipressin has been shown to be effective in the management of hepatorenal syndrome. "
|3.||Hypotension (Low Blood Pressure)
11/01/2011 - "Although the number of reported infants is little, terlipressin appears to be an effective rescue treatment in different scenarios of refractory neonatal hypotension. "
04/01/2008 - "Terlipressin promptly reversed hypotension and improved tissue perfusion without adverse effects. "
11/01/2011 - "The aim of this study is to describe original clinical scenarios in which terlipressin, in newborns and infants, resolved the catecholamine-refractory hypotension. "
01/01/2010 - "The objective of this study was to report the effects of Terlipressin treatment in 2 potential organ donors with intractable, catecholamine-resistant hypotension. "
01/01/2013 - "terlipressin) in decreasing mortality and adverse neurodevelopmental outcomes, and improving survival in neonates with refractory hypotension. "
08/01/2002 - "In patients with type 1 HRS treated with terlipressin, patients with improved renal function had less severe cirrhosis (Child-Pugh >10 but < or =13) than patients without. "
01/01/2010 - "The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. Thirty-nine patients with cirrhosis and type 1 HRS were treated prospectively with terlipressin and albumin. "
11/01/2009 - "The aim of the present study was to assess the effects of terlipressin on systemic, hepatic and renal hemodynamics in cirrhosis. "
05/01/2008 - "The aim of this study was to evaluate the efficacy and safety of terlipressin, a systemic arterial vasoconstrictor, for cirrhosis type 1 HRS. A prospective, randomized, double-blind, placebo-controlled clinical trial of terlipressin was performed. "
01/01/2006 - "Therefore, the aim of the present study was to investigate the preventive effect of terlipressin on paracentesis-induced circulatory dysfunction in patients with cirrhosis after therapeutic paracentesis and compared with that of intravenous albumin. "
|5.||Septic Shock (Toxic Shock Syndrome)
06/01/2011 - "In fluid-resuscitated patients with septic shock (with a MAP between 65 and 75 mmHg), a bolus infusion of 0.5 mg terlipressin was effective in reducing NE requirements without worsening microcirculatory blood flow. "
10/01/2006 - "Our data suggest that terlipressin is effective in septic shock. "
06/01/2011 - "The objective of the present study was, therefore, to elucidate the effects of a single terlipressin bolus dose of 0.5 mg on microcirculatory perfusion in patients with catecholamine-dependent septic shock. "
01/01/2009 - "Use of terlipressin in septic shock relies on a series of European studies resulting in a better knowledge of this vasopressive agent. "
06/01/2008 - "Future studies are required before any recommendations on the use of terlipressin in children with septic shock can be made."
|2.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|7.||Arginine Vasopressin (Argipressin)
|8.||Nitric Oxide (Nitrogen Monoxide)